Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50!

Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50!

We are delighted by this recognition of our work as a North East-based CDMO that serves the global Pharma industry, and it’s also a great example of how ‘outsourcing favours the brave’.

Thank you to all our customers and partners that have helped us on our journey.

Find out more in the latest issue from PharmaTimes Media Ltd




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.